Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients

Journal of Human Hypertension volume 30, pages 685–689 (2016)Cite this article

Subjects

Abstract

Microalbuminuria is an established early marker of endothelial dysfunction and damage. MicroRNAs (miRNAs) are emerging as essential modulators of cardiovascular physiology and disease. In the present study, we sought an association between the differential expression of related miRNAs in the peripheral blood mononuclear cells of untreated patients with newly diagnosed essential hypertension and the levels of urinary albumin excretion. We assessed the expression of the miRNAs miRNA-1, miRNA-133a, miRNA-26b, miRNA-208b, miRNA-499 and miRNA-21 in consecutive subjects with untreated newly diagnosed essential hypertension (aged 62.5±9.7 years) and with no indications of other organic heart disease. MiRNA expression levels in peripheral blood mononuclear cells were quantified by real-time reverse transcription-polymerase chain reaction. The prevalence of microalbuminuria was 9.8%. miRNA-208b and miRNA-133a were independently correlated with 24-h urinary albumin excretion. More specifically, a strong association was found between the gene expression levels of miRNA-208b in our patients’ peripheral blood cells and urinary albumin (r=0.72, P<0.001). A similar association was found for miRNA-133a (r=0.372, P<0.001). In conclusion, miRNA-208b and miRNA-133a show distinct profiling in peripheral blood cells isolated from untreated patients with recently diagnosed essential hypertension. Their gene expression levels reveal a strong correlation with urinary albumin excretion levels. Our findings provide new perspectives on the development of a new generation of biomarkers for the better monitoring of end-organ damage in hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell’Omo G, Catapano G et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14–18.

    Article  CAS  Google Scholar 

  2. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M . Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 2002; 16: 79–89.

    Article  CAS  Google Scholar 

  3. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357.

    Article  CAS  Google Scholar 

  4. Abdellatif M . Differential expression of microRNAs in different disease states. Circ Res 2012; 110: 638–650.

    Article  CAS  Google Scholar 

  5. Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012; 14: 249–256.

    Article  CAS  Google Scholar 

  6. Small EM, Olson EN . Pervasive roles of microRNAs in cardiovascular biology. Nature 2011; 469: 336–342.

    Article  CAS  Google Scholar 

  7. Condorelli G, Latronico MV, Cavarretta E . microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol 2014; 63: 2177–2187.

    Article  CAS  Google Scholar 

  8. Vickers KC, Rye KA, Tabet F . MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (London, England: 1979) 2014; 126: 183–194.

    Article  CAS  Google Scholar 

  9. Fiedler J, Thum T . MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol 2013; 33: 201–205.

    Article  CAS  Google Scholar 

  10. Da Costa Martins PA, De Windt LJ . MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 2012; 93: 563–572.

    Article  CAS  Google Scholar 

  11. Liang M, Liu Y, Mladinov D, Cowley AW Jr, Trivedi H, Fang Y et al. MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol 2009; 297: F553–F558.

    Article  CAS  Google Scholar 

  12. Kontaraki J, Marketou M, Parthenakis FI,, Maragkoudakis S, Zacharis E, Petousis S et al Hypertrophic and anti-hypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension. J Am Soc Hypertens 2015; 9: 802–810.

    Article  CAS  Google Scholar 

  13. Crippa G . Microalbuminuria in essential hypertension. J Hum Hypertens 2002; 16: S74–S77.

    Article  Google Scholar 

  14. Bigazzi R, Bianchi S, Baldari D, Campese VM . Microalbuminuriapredicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16: 1325–1333.

    Article  CAS  Google Scholar 

  15. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969–975.

    Article  Google Scholar 

  16. Tsioufis CP, Lambrou SG, Stefanadis CI, Antoniadis DI, KallikazarosIE, Pitsavos CE et al. Microalbuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension. Am J Cardiol 2000; 86: 797–801.

    Article  CAS  Google Scholar 

  17. Klausen KP, Scharling H, Jensen G, Jensen JS . New definition of microalbuminuria in hypertensive subjects association with incident coronary heart disease and death. Hypertension 2005; 46: 33–37.

    Article  CAS  Google Scholar 

  18. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834–838.

    Article  CAS  Google Scholar 

  19. Creemers EE, Tijsen AJ, Pinto YM . Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012; 110: 483–495.

    Article  CAS  Google Scholar 

  20. van Rooij E, Purcell AL, Levin AA . Developing microRNA therapeutics. Circ Res 2012; 110: 496–507.

    Article  CAS  Google Scholar 

  21. Bátkai S, Thum T . MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep 2012; 14: 79–87.

    Article  Google Scholar 

  22. Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, Kim HS et al. Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Coll Cardiol 2003; 42: 905–910.

    Article  CAS  Google Scholar 

  23. Zapolska-Donar D, Siennicka A, Chełstowski K, Widecka K, Goracy I, Hałasa M et al. Is there an association between angiotensin-converting enzyme gene polymorphism and functional activation of monocytes and macrophage in young patients with essential hypertension? J Hypertens 2006; 24: 1565–1573.

    Article  Google Scholar 

  24. Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE . MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage. J Am Soc Hypertens 2014; 8: 368–375.

    Article  CAS  Google Scholar 

  25. Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE . Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens 2014; 28: 510–516.

    Article  CAS  Google Scholar 

  26. Das S, Halushka MK . Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol 2015; 24: 199–206.

    Article  CAS  Google Scholar 

  27. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007; 104: 3432–3437.

    Article  CAS  Google Scholar 

  28. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008; 22: 4126–4135.

    Article  CAS  Google Scholar 

  29. Peng H, Zhong M, Zhao W, Wang C, Zhang J, Liu X et al. Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients. PLoS ONE 2013; 8: e82607.

    Article  Google Scholar 

  30. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009; 104: 170–178.

    Article  CAS  Google Scholar 

  31. Kumarswamy R, Thum T . Non-coding RNAs in cardiac remodeling and heart failure. Circ Res 2013; 113: 676–689.

    Article  CAS  Google Scholar 

  32. Wang F, Long G, Zhao C, Li H, Chaugai S, Wang Y et al. Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Trans Med 2013; 11: 222.

    Article  Google Scholar 

  33. Castoldi G, Di Gioia CR, Bombardi C, Catalucci D, Corradi B, Gualazzi MG et al. MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol 2012; 227: 850–856.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Heraklion University Hospital, Heraklion, Greece

    F I Parthenakis, M E Marketou, F Maragoudakis, S Maragkoudakis, H Nakou, K Roufas, A Patrianakos & P E Vardas

  2. Molecular Cardiology Laboratory, School of Medicine, University of Crete, Heraklion, Greece

    J E Kontaraki

  3. Division of Biostatistics, School of Medicine, University of Crete, Heraklion, Greece

    G Chlouverakis

  4. Department of Clinical Chemistry–Biochemistry, Heraklion University Hospital, Heraklion, Greece

    N Malliaraki

Authors
  1. F I Parthenakis
    View author publications

    Search author on:PubMed Google Scholar

  2. M E Marketou
    View author publications

    Search author on:PubMed Google Scholar

  3. J E Kontaraki
    View author publications

    Search author on:PubMed Google Scholar

  4. F Maragoudakis
    View author publications

    Search author on:PubMed Google Scholar

  5. S Maragkoudakis
    View author publications

    Search author on:PubMed Google Scholar

  6. H Nakou
    View author publications

    Search author on:PubMed Google Scholar

  7. K Roufas
    View author publications

    Search author on:PubMed Google Scholar

  8. A Patrianakos
    View author publications

    Search author on:PubMed Google Scholar

  9. G Chlouverakis
    View author publications

    Search author on:PubMed Google Scholar

  10. N Malliaraki
    View author publications

    Search author on:PubMed Google Scholar

  11. P E Vardas
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to M E Marketou.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parthenakis, F., Marketou, M., Kontaraki, J. et al. Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients. J Hum Hypertens 30, 685–689 (2016). https://doi.org/10.1038/jhh.2016.15

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/jhh.2016.15

This article is cited by

Search

Advanced search

Quick links